Closed · RFA-TS-26-165 · CFDA 93.061 · Discretionary

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

up to $500K
Award range
Closed
Status
June 10, 2026
Close date
3
Expected awards

The verdict

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $500,000 across 3 expected awards. Future funding cycles may be published under the same CFDA number.

up to $500K
award range
Closed
application status
3
expected awards
93.061
CFDA program

Opportunity snapshot. This Grants.gov announcement - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) - is cataloged under number RFA-TS-26-165 and tied to CFDA assistance listing 93.061, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on May 11, 2026. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Up to $500,000. The agency has projected $4.5 million in total estimated funding for this announcement. It expects to issue 3 awards. If the agency funds the expected 3 awards from the $4.5 million estimated pool, the average award works out to roughly $1.5 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on June 10, 2026. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Up to $500,000

Close Date

June 10, 2026

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Posted

May 11, 2026

Est. Total Funding

$4,500,000

Expected Awards

3

Instrument

Cooperative Agreement

Description

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Dr. Candis Hunter ncipc_erpo@cdc.gov

Key Dates

Posted May 11, 2026
Close Date June 10, 2026
Archive Date May 12, 2027
Last Updated May 11, 2026

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)", offered by Centers for Disease Control and Prevention - ERA. It is associated with CFDA program 93.061. CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infe...
Is this opportunity still open?
No, this opportunity is closed. It closed on June 10, 2026. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Up to $500,000. Total estimated funding: $4,500,000. Expected number of awards: 3.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants